Via the AdipoR1/AMPK/SIRT1/SREBP2 signaling pathway, osmotin diminishes amyloidogenic Aβ production and aggregation, accompanied by improved pre- and post-synaptic dysfunction, cognitive impairment, memory deficits and long-term potentiation. This evidence concerns the gene SIRT1 and Cognitive impairment.